Home » Newsletters » BioWorld Science

BioWorld Science

June 15, 2010

View Archived Issues

Nerviano Medical Sciences discloses new HSP 90 inhibitors

Merck KGaA identifies new series of Sgk1 inhibitors

Roche discloses new vasopressin V1A receptor antagonists

MGMTP140K-modified CD34+ stem cells efficiently engrafted into patients with glioblastoma

UCB presents novel PI3K inhibitors

Servier discovers novel melatonin receptor ligands

Armodafinil evaluated in healthy subjects and in patients with excessive sleepiness

CSPG4 may represent prognostic biomarker for chordoma

R-7160 evaluated in phase I/II trial in solid tumors

Cook Medical submits PMA for paclitaxel-eluting stent to FDA

FDA grants orphan status to ImmunoCellular's ICT-107 vaccine for GBM

Telormedix begins phase I/II TMX-101 trial in non-muscle-invasive bladder cancer

ProSavin is safe and improves motor scores in Parkinson's disease

Upsher-Smith Laboratories initiates phase III USL-255 trial

UCB launches new oral solution of antiepileptic drug Vimpat

Phase III NExUS trial of sorafenib in NSCLC does not meet primary endpoint

FDA issues complete response letter to GSK for MenHibrix vaccine

Esperion and Cleveland Clinic to collaborate on HDL therapies for cardiovascular disease

Takeda receives pricing approval for Nesina in Japan

Faron and Priaxon to develop new AOC3/SSAO antagonists

FDA gives preliminary feedback on HGS' Zalbin BLA for chronic hepatitis C

Agile Therapeutics secures funds to advance AG-200-15 and AG-1000

FDA continues safety review of Benicar trial data in type 2 diabetes

FDA grants fast track status to Genzyme's alemtuzumab for MS

Almirall and Basilea join to commercialize Toctino for severe CHE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.